(3R,4S)-1-benzyl-N,4-di-methylpiperidin-3-amine dihydrochloride
Tofacitinib Impurity 19 is listed by Simson Pharma as a impurity standards for laboratory research, analytical development and quality-control workflows.
Suitability is method- and purpose-specific. Before use, verify the product name, catalogue number, chemical identifiers, storage requirements and the information reported in the current product or batch documentation. Your laboratory remains responsible for method qualification or validation.
Tofacitinib Impurity 19 for method validation Tofacitinib Impurity 19 reference standard Tofacitinib Impurity 19 for ANDA filing Tofacitinib Impurity 19 for forced degradation studies Tofacitinib Impurity 19 identification standard Tofacitinib Impurity 19 for DMF filing Tofacitinib Impurity 19 HPLC standard Tofacitinib Impurity 19 supplier Tofacitinib Impurity 19 manufacturer Tofacitinib Impurity 19 distributor
